These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34054876)

  • 1. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course.
    Miedema J; Schreurs M; van der Sar-van der Brugge S; Paats M; Baart S; Bakker M; Hoek R; Dik WA; Endeman H; Van Der Velden V; van Gammeren A; Ermens A; Aerts JG; Thüsen JV
    Front Immunol; 2021; 12():684142. PubMed ID: 34054876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients.
    Miedema JR; Janssen ML; von der Thüsen J; Endeman H; Langerak AW; Hellemons ME; van Nood E; Peeters BWA; Baart SJ; Schreurs MWJ
    Front Immunol; 2023; 14():1204433. PubMed ID: 37622126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
    Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
    J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
    El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
    Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
    Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
    Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Zmonarski S; Mazanowska O; Krajewska M; Bartoszek D; Zabińska M; Myszka M; Kamińska M; Hałoń A; Dawiskiba T; Szyber P; Sas A; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
    O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D
    Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
    Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
    Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C; Kang ZY; Yin Z; Xiao Y; Liu W; Zhao Y; Li DH
    Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In arterial occlusive disease autoantibodies against ETAR and AT(1)R correlate with each other but are not associated with classical cardiovascular risk factors.
    Albert C; von Schultzendorff M; Şalaru D; Halloul Z; Dragun D; Heidecke H; Mertens PR
    Vasa; 2014 Mar; 43(2):113-23. PubMed ID: 24627317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
    Civieri G; Iop L; Tona F
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.
    Philogene MC; Johnson T; Vaught AJ; Zakaria S; Fedarko N
    Hum Immunol; 2019 Aug; 80(8):561-567. PubMed ID: 31010696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelial dysfunction in the severity of COVID‑19 infection (Review).
    Kadiyska T; Tourtourikov I; Dabchev K; Cherneva R; Stoynev N; Hadjiolova R; Mitev V; Spandidos DA; Adamaki M; Zoumpourlis V
    Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36196882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
    Jiang Y; Duffy F; Hadlock J; Raappana A; Styrchak S; Beck I; Mast FD; Miller LR; Chour W; Houck J; Armistead B; Duvvuri VR; Yeung W; Haglund M; Wallner J; Wallick JA; Hardy S; Oldroyd A; Ko D; Gervassi A; Murray KM; Kaplan H; Aitchison JD; Heath JR; Sather DN; Goldman JD; Frenkel L; Harrington WE
    PLoS One; 2021; 16(11):e0259902. PubMed ID: 34788328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy.
    Salaru DL; Albert C; Königsmark U; Brandt S; Halloul Z; Heller A; Heidecke H; Dragun D; Mertens PR
    Int Angiol; 2014 Aug; 33(4):372-8. PubMed ID: 25056169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
    Pearl MH; Chen L; Zuckerman JE; Weng PL; Chambers ET; Zhang Q; Reed EF
    Transplantation; 2024 Jan; 108(1):276-283. PubMed ID: 37527494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
    Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation.
    Gerlach UA; Lachmann N; Ranucci G; Sawitzki B; Schoenemann C; Pratschke J; Dragun D; Pascher A
    Transplantation; 2017 Jan; 101(1):141-149. PubMed ID: 27495766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-transplant AT
    Gareau AJ; Wiebe C; Pochinco D; Gibson IW; Ho J; Rush DN; Nickerson PW
    Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.
    Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y
    J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.